4.4 Article

Development of Sandwich Double-Competitive ELISA for Sulfonamides. Comparative Analytical Characteristics and Matrix Effect Resistance

Journal

FOOD ANALYTICAL METHODS
Volume 11, Issue 3, Pages 663-674

Publisher

SPRINGER
DOI: 10.1007/s12161-017-1036-6

Keywords

Sandwich competitive immunoassay; Direct and indirect format; Sulfonamides; Matrix effect

Funding

  1. NSFC [31372475]

Ask authors/readers for more resources

Sandwich enzyme-linked immunosorbent assay (ELISA) of sulfonamides based on double-competitive interaction between haptenized protein as a captured antigen and analyte for binding to immobilized and enzyme-labeled antibodies was developed. This experimental assay format was examined in analytical properties and matrix effect resistance in comparison with usual ones: indirect, direct antigen-coated and antibody-coated ELISAs. All four assay formats were designed on the basis of interactions between the previously prepared monoclonal antibody and immunizing hapten, 4-(4-(4-aminophenylsulfonamido) phenyl)butanoic acid, providing the uniform output optical signal for correct comparison of each assay characteristic. The sensitivity (IC50) of the developed competitive sandwich assay was rather below 100 ng/ml for 11 sulfonamides which was suitable for their determination in milk, muscles and animal sera at established maximum residue limit concentration. Comparative examination did not reveal changes in assay specificity, and advantages in sensitivity, matrix effect resistance, and procedure duration before commonly used assay formats. Moreover, new design of assay was shown to be three-fold more consumable in antibody reagents in comparison with direct assay formats.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

Comparative polymyxin B pharmacokinetics in patients receiving extracorporeal membrane oxygenation

Yury A. Surovoy, Maksim A. Burkin, Inna A. Galvidis, Pavel O. Bochkov, Armen V. Oganesyan, Sergei V. Tsarenko

Summary: This study aimed to describe the pharmacokinetics of polymyxin B in patients receiving veno-venous extracorporeal membrane oxygenation (ECMO) compared to critically ill patients without ECMO support. The results showed that the currently recommended dosage of polymyxin B is sufficient for ECMO patients and no dosage increase is required.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Article Food Science & Technology

Influence of Endogenous Factors of Food Matrices on Avidin-Biotin Immunoassays for the Detection of Bacitracin and Colistin in Food

Maksim A. Burkin, Inna A. Galvidis, Sergei A. Eremin

Summary: The study found that the presence of avidin and biotin in food matrices may interfere with the accuracy of (strept)avidin-biotin-based immunoanalytical systems for food safety. Competitive ELISA methods based on hapten-protein coating conjugates and biotinylated analytes bound to immobilized streptavidin showed improved sensitivity in the determination of bacitracin and colistin. These methods also allowed for the assessment of avidin and biotin content in food matrices.

FOODS (2022)

Article Chemistry, Analytical

Immunoassay for Natamycin Trace Screening: Bread, Wine and Other Edibles Analysis

Maksim A. Burkin, Anastasia G. Moshcheva, Inna A. Galvidis

Summary: This work focuses on developing an immunoassay to investigate the widespread use of natamycin (NAT) in food preservation. By designing immunogens and optimizing the extraction procedure, a sensitive ELISA variant was developed for the detection of NAT. The screening examination revealed the undeclared use of NAT in yogurt products.

BIOSENSORS-BASEL (2022)

Article Chemistry, Analytical

Development and application of amphotericin B immunoassay for pharmacokinetic studies and therapeutic drug monitoring in critically ill patients

Maksim A. Burkin, Yuri A. Surovoy, Vera G. Arzumanian, Inna A. Galvidis

Summary: This study developed a novel immunoassay for ATB in human serum samples, providing crucial support for clinical dosing and monitoring in patients.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)

Article Chemistry, Analytical

Unbound serum polymyxin B in patients with sepsis: Detection approaches and limited sampling strategy for clinical practice and research

Inna A. Galvidis, Yury A. Surovoy, Gleb S. Perevoznyuk, Sergei V. Tsarenko, Maksim A. Burkin

Summary: Polymyxins are used to treat multidrug resistant bacteria, but their narrow therapeutic window and variable pharmacokinetics in critically ill patients pose risks of toxicity and underdosing. This study explored methods for determining unbound polymyxin B (PMB) and proposed limited sampling strategies for clinical application. Rapid equilibrium dialysis demonstrated lower non-specific binding compared to ultrafiltration, making it a more reliable tool. The study also suggested using 1-3 sampling points and Bayesian estimation as an alternative approach.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)

Article Pharmacology & Pharmacy

Comparative polymyxin B pharmacokinetics in critically ill patients with renal insufficiency and in continuous veno-venous hemodialysis

Yury A. Surovoy, Maksim A. Burkin, Inna A. Galvidis, Mikhail A. Sobolev, Onur Can Rende, Sergei Tsarenko

Summary: This study assesses the pharmacokinetics of polymyxin B in patients with varying degrees of renal dysfunction and in patients requiring continuous veno-venous hemodialysis. The results show that patients with renal insufficiency had higher serum concentrations of polymyxin B, indicating a higher risk of toxicity. For patients on CVVHD, a fixed maintenance dose of 100 mg q12h is recommended.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Chemistry, Analytical

Tigecycline Immunodetection Using Developed Group-Specific and Selective Antibodies for Drug Monitoring Purposes

Inna A. Galvidis, Yury A. Surovoy, Sergei V. Tsarenko, Maksim A. Burkin

Summary: Tigecycline (TGC) is a potent and broad-spectrum antibiotic that can overcome tetracycline resistance. To improve safety and efficacy, an immunodetection method using TGC selective antibodies and group-specific antibodies was developed for therapeutic drug monitoring. The method showed high sensitivity and satisfactory recovery rates in healthy volunteers and COVID-19 patients with secondary bacterial infections. Pharmacokinetic study conducted in critically ill patients supported the suitability of the test for individual therapy monitoring and population pharmacokinetic modeling.

BIOSENSORS-BASEL (2023)

Article Chemistry, Analytical

Immunotechniques for the Group Determination of Macrolide Antibiotics Traces in the Environment Using a Volume-Mediated Sensitivity Enhancement Strategy

Maksim A. Burkin, Anna N. Tevyashova, Elena N. Bychkova, Artem O. Melekhin, Inna A. Galvidis

Summary: Macrolide antibiotics are widely used in medicine, veterinary medicine, and agriculture, resulting in their presence as environmental pollutants worldwide. This study presents an underexploited strategy to enhance the detectability of macrolides in environmental samples by analyzing larger volumes of test samples. The proposed method significantly improved assay sensitivity and detection limit by more than 50-fold.

BIOSENSORS-BASEL (2023)

No Data Available